The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Europium Nanoparticle in Biological Sector Market Research Report 2024
Synopsis
Europium (Eu), a rare earth element, has been widely explored for its applications in biological immunofluorescence diagnosis due to its unique luminescent properties. Here is an overview of why and how it's used: Long Fluorescence Lifetimes: Europium complexes have fluorescence lifetimes of microseconds to milliseconds, which are significantly longer than conventional organic fluorophores. This time gap allows researchers to perform time-gated detection, reducing autofluorescence from biomolecules and background noise, thus improving the sensitivity and accuracy of assays. High Stability: Europium chelates or cryptates are highly stable, providing consistent fluorescence signals that don't photobleach. The stability of these fluorescent compounds ensures the reliability of diagnostic tests over extended periods. Sharp Emission Spectra: Europium complexes exhibit sharp emission spectral peaks, which enables multiplexing, meaning several different probes can be detected simultaneously without overlap. This is particularly useful in high-throughput screening or when it's necessary to detect multiple targets at once. In terms of application in biological immunofluorescence diagnosis, europium-labeled immunoassays are commonly used. These techniques involve creating a complex between europium and an antibody specific to the target antigen. When the antigen is present, the europium-labelled antibody binds to it. The resulting complex can then be detected through the characteristic fluorescence of europium, allowing accurate identification and quantification of the target antigen. Overall, the use of europium in biological immunofluorescence diagnostics continues to be a promising field, potentially contributing to the development of more accurate, sensitive, and high-throughput diagnostic methods.
The global Europium Nanoparticle in Biological Sector market was valued at US$ 13 million in 2023 and is anticipated to reach US$ 23.6 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
Global key players of Europium Nanoparticle in Biological Sector include Thermo Fisher Scientific, Merck, Suzhou NanoMicro Technology Co, etc. The top three players hold a share over 76%. North America is the largest market, and has a share about 32%, followed by China and Europe with share 25% and 23%, separately. In terms of product type, 200 nm is the largest segment, occupied for a share of 47%. In terms of application, Tumor Marker Testing has a share about 27 percent.
This report aims to provide a comprehensive presentation of the global market for Europium Nanoparticle in Biological Sector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Europium Nanoparticle in Biological Sector.
The Europium Nanoparticle in Biological Sector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Europium Nanoparticle in Biological Sector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Europium Nanoparticle in Biological Sector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microoetection
Segment by Type
300 nm
200 nm
100 nm
Other
Segment by Application
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Europium Nanoparticle in Biological Sector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Europium (Eu), a rare earth element, has been widely explored for its applications in biological immunofluorescence diagnosis due to its unique luminescent properties. Here is an overview of why and how it's used: Long Fluorescence Lifetimes: Europium complexes have fluorescence lifetimes of microseconds to milliseconds, which are significantly longer than conventional organic fluorophores. This time gap allows researchers to perform time-gated detection, reducing autofluorescence from biomolecules and background noise, thus improving the sensitivity and accuracy of assays. High Stability: Europium chelates or cryptates are highly stable, providing consistent fluorescence signals that don't photobleach. The stability of these fluorescent compounds ensures the reliability of diagnostic tests over extended periods. Sharp Emission Spectra: Europium complexes exhibit sharp emission spectral peaks, which enables multiplexing, meaning several different probes can be detected simultaneously without overlap. This is particularly useful in high-throughput screening or when it's necessary to detect multiple targets at once. In terms of application in biological immunofluorescence diagnosis, europium-labeled immunoassays are commonly used. These techniques involve creating a complex between europium and an antibody specific to the target antigen. When the antigen is present, the europium-labelled antibody binds to it. The resulting complex can then be detected through the characteristic fluorescence of europium, allowing accurate identification and quantification of the target antigen. Overall, the use of europium in biological immunofluorescence diagnostics continues to be a promising field, potentially contributing to the development of more accurate, sensitive, and high-throughput diagnostic methods.
The global Europium Nanoparticle in Biological Sector market was valued at US$ 13 million in 2023 and is anticipated to reach US$ 23.6 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
Global key players of Europium Nanoparticle in Biological Sector include Thermo Fisher Scientific, Merck, Suzhou NanoMicro Technology Co, etc. The top three players hold a share over 76%. North America is the largest market, and has a share about 32%, followed by China and Europe with share 25% and 23%, separately. In terms of product type, 200 nm is the largest segment, occupied for a share of 47%. In terms of application, Tumor Marker Testing has a share about 27 percent.
This report aims to provide a comprehensive presentation of the global market for Europium Nanoparticle in Biological Sector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Europium Nanoparticle in Biological Sector.
The Europium Nanoparticle in Biological Sector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Europium Nanoparticle in Biological Sector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Europium Nanoparticle in Biological Sector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microoetection
Segment by Type
300 nm
200 nm
100 nm
Other
Segment by Application
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Europium Nanoparticle in Biological Sector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Europium Nanoparticle in Biological Sector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 300 nm
1.2.3 200 nm
1.2.4 100 nm
1.2.5 Other
1.3 Market by Application
1.3.1 Global Europium Nanoparticle in Biological Sector Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor Marker Testing
1.3.3 Thyroid Function Testing
1.3.4 Sex Hormone Testing
1.3.5 Infectious Disease Testing
1.3.6 Cardiovascular and Cardiac Biomarkers Testing
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Europium Nanoparticle in Biological Sector Market Perspective (2019-2030)
2.2 Global Europium Nanoparticle in Biological Sector Growth Trends by Region
2.2.1 Global Europium Nanoparticle in Biological Sector Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Europium Nanoparticle in Biological Sector Historic Market Size by Region (2019-2024)
2.2.3 Europium Nanoparticle in Biological Sector Forecasted Market Size by Region (2025-2030)
2.3 Europium Nanoparticle in Biological Sector Market Dynamics
2.3.1 Europium Nanoparticle in Biological Sector Industry Trends
2.3.2 Europium Nanoparticle in Biological Sector Market Drivers
2.3.3 Europium Nanoparticle in Biological Sector Market Challenges
2.3.4 Europium Nanoparticle in Biological Sector Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Europium Nanoparticle in Biological Sector Players by Revenue
3.1.1 Global Top Europium Nanoparticle in Biological Sector Players by Revenue (2019-2024)
3.1.2 Global Europium Nanoparticle in Biological Sector Revenue Market Share by Players (2019-2024)
3.2 Global Europium Nanoparticle in Biological Sector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Europium Nanoparticle in Biological Sector Revenue
3.4 Global Europium Nanoparticle in Biological Sector Market Concentration Ratio
3.4.1 Global Europium Nanoparticle in Biological Sector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Europium Nanoparticle in Biological Sector Revenue in 2023
3.5 Global Key Players of Europium Nanoparticle in Biological Sector Head office and Area Served
3.6 Global Key Players of Europium Nanoparticle in Biological Sector, Product and Application
3.7 Global Key Players of Europium Nanoparticle in Biological Sector, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Europium Nanoparticle in Biological Sector Breakdown Data by Type
4.1 Global Europium Nanoparticle in Biological Sector Historic Market Size by Type (2019-2024)
4.2 Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Type (2025-2030)
5 Europium Nanoparticle in Biological Sector Breakdown Data by Application
5.1 Global Europium Nanoparticle in Biological Sector Historic Market Size by Application (2019-2024)
5.2 Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Europium Nanoparticle in Biological Sector Market Size (2019-2030)
6.2 North America Europium Nanoparticle in Biological Sector Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024)
6.4 North America Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Europium Nanoparticle in Biological Sector Market Size (2019-2030)
7.2 Europe Europium Nanoparticle in Biological Sector Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024)
7.4 Europe Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Europium Nanoparticle in Biological Sector Market Size (2019-2030)
8.2 Asia-Pacific Europium Nanoparticle in Biological Sector Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Europium Nanoparticle in Biological Sector Market Size by Region (2019-2024)
8.4 Asia-Pacific Europium Nanoparticle in Biological Sector Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Europium Nanoparticle in Biological Sector Market Size (2019-2030)
9.2 Latin America Europium Nanoparticle in Biological Sector Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024)
9.4 Latin America Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Europium Nanoparticle in Biological Sector Market Size (2019-2030)
10.2 Middle East & Africa Europium Nanoparticle in Biological Sector Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024)
10.4 Middle East & Africa Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Europium Nanoparticle in Biological Sector Introduction
11.1.4 Thermo Fisher Scientific Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Europium Nanoparticle in Biological Sector Introduction
11.2.4 Merck Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Bangs Laboratories, Inc.
11.3.1 Bangs Laboratories, Inc. Company Details
11.3.2 Bangs Laboratories, Inc. Business Overview
11.3.3 Bangs Laboratories, Inc. Europium Nanoparticle in Biological Sector Introduction
11.3.4 Bangs Laboratories, Inc. Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.3.5 Bangs Laboratories, Inc. Recent Development
11.4 Suzhou NanoMicro Technology Co
11.4.1 Suzhou NanoMicro Technology Co Company Details
11.4.2 Suzhou NanoMicro Technology Co Business Overview
11.4.3 Suzhou NanoMicro Technology Co Europium Nanoparticle in Biological Sector Introduction
11.4.4 Suzhou NanoMicro Technology Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.4.5 Suzhou NanoMicro Technology Co Recent Development
11.5 Polysciences Inc
11.5.1 Polysciences Inc Company Details
11.5.2 Polysciences Inc Business Overview
11.5.3 Polysciences Inc Europium Nanoparticle in Biological Sector Introduction
11.5.4 Polysciences Inc Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.5.5 Polysciences Inc Recent Development
11.6 CD Bioparticles
11.6.1 CD Bioparticles Company Details
11.6.2 CD Bioparticles Business Overview
11.6.3 CD Bioparticles Europium Nanoparticle in Biological Sector Introduction
11.6.4 CD Bioparticles Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.6.5 CD Bioparticles Recent Development
11.7 Hangzhou Bioeast Biotech Co
11.7.1 Hangzhou Bioeast Biotech Co Company Details
11.7.2 Hangzhou Bioeast Biotech Co Business Overview
11.7.3 Hangzhou Bioeast Biotech Co Europium Nanoparticle in Biological Sector Introduction
11.7.4 Hangzhou Bioeast Biotech Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.7.5 Hangzhou Bioeast Biotech Co Recent Development
11.8 Nanjing Microoetection
11.8.1 Nanjing Microoetection Company Details
11.8.2 Nanjing Microoetection Business Overview
11.8.3 Nanjing Microoetection Europium Nanoparticle in Biological Sector Introduction
11.8.4 Nanjing Microoetection Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
11.8.5 Nanjing Microoetection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Europium Nanoparticle in Biological Sector Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 300 nm
Table 3. Key Players of 200 nm
Table 4. Key Players of 100 nm
Table 5. Key Players of Other
Table 6. Global Europium Nanoparticle in Biological Sector Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Europium Nanoparticle in Biological Sector Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Europium Nanoparticle in Biological Sector Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Europium Nanoparticle in Biological Sector Market Share by Region (2019-2024)
Table 10. Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Europium Nanoparticle in Biological Sector Market Share by Region (2025-2030)
Table 12. Europium Nanoparticle in Biological Sector Market Trends
Table 13. Europium Nanoparticle in Biological Sector Market Drivers
Table 14. Europium Nanoparticle in Biological Sector Market Challenges
Table 15. Europium Nanoparticle in Biological Sector Market Restraints
Table 16. Global Europium Nanoparticle in Biological Sector Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Europium Nanoparticle in Biological Sector Market Share by Players (2019-2024)
Table 18. Global Top Europium Nanoparticle in Biological Sector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Europium Nanoparticle in Biological Sector as of 2023)
Table 19. Ranking of Global Top Europium Nanoparticle in Biological Sector Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Europium Nanoparticle in Biological Sector Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Europium Nanoparticle in Biological Sector, Headquarters and Area Served
Table 22. Global Key Players of Europium Nanoparticle in Biological Sector, Product and Application
Table 23. Global Key Players of Europium Nanoparticle in Biological Sector, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Europium Nanoparticle in Biological Sector Revenue Market Share by Type (2019-2024)
Table 27. Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Europium Nanoparticle in Biological Sector Revenue Market Share by Type (2025-2030)
Table 29. Global Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Europium Nanoparticle in Biological Sector Revenue Market Share by Application (2019-2024)
Table 31. Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Europium Nanoparticle in Biological Sector Revenue Market Share by Application (2025-2030)
Table 33. North America Europium Nanoparticle in Biological Sector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Europium Nanoparticle in Biological Sector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Europium Nanoparticle in Biological Sector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Europium Nanoparticle in Biological Sector Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Europium Nanoparticle in Biological Sector Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Europium Nanoparticle in Biological Sector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Europium Nanoparticle in Biological Sector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Europium Nanoparticle in Biological Sector Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Europium Nanoparticle in Biological Sector Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Details
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Europium Nanoparticle in Biological Sector Product
Table 51. Thermo Fisher Scientific Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Merck Company Details
Table 54. Merck Business Overview
Table 55. Merck Europium Nanoparticle in Biological Sector Product
Table 56. Merck Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Bangs Laboratories, Inc. Company Details
Table 59. Bangs Laboratories, Inc. Business Overview
Table 60. Bangs Laboratories, Inc. Europium Nanoparticle in Biological Sector Product
Table 61. Bangs Laboratories, Inc. Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 62. Bangs Laboratories, Inc. Recent Development
Table 63. Suzhou NanoMicro Technology Co Company Details
Table 64. Suzhou NanoMicro Technology Co Business Overview
Table 65. Suzhou NanoMicro Technology Co Europium Nanoparticle in Biological Sector Product
Table 66. Suzhou NanoMicro Technology Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 67. Suzhou NanoMicro Technology Co Recent Development
Table 68. Polysciences Inc Company Details
Table 69. Polysciences Inc Business Overview
Table 70. Polysciences Inc Europium Nanoparticle in Biological Sector Product
Table 71. Polysciences Inc Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 72. Polysciences Inc Recent Development
Table 73. CD Bioparticles Company Details
Table 74. CD Bioparticles Business Overview
Table 75. CD Bioparticles Europium Nanoparticle in Biological Sector Product
Table 76. CD Bioparticles Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 77. CD Bioparticles Recent Development
Table 78. Hangzhou Bioeast Biotech Co Company Details
Table 79. Hangzhou Bioeast Biotech Co Business Overview
Table 80. Hangzhou Bioeast Biotech Co Europium Nanoparticle in Biological Sector Product
Table 81. Hangzhou Bioeast Biotech Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 82. Hangzhou Bioeast Biotech Co Recent Development
Table 83. Nanjing Microoetection Company Details
Table 84. Nanjing Microoetection Business Overview
Table 85. Nanjing Microoetection Europium Nanoparticle in Biological Sector Product
Table 86. Nanjing Microoetection Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024) & (US$ Million)
Table 87. Nanjing Microoetection Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Europium Nanoparticle in Biological Sector Picture
Figure 2. Global Europium Nanoparticle in Biological Sector Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Europium Nanoparticle in Biological Sector Market Share by Type: 2023 VS 2030
Figure 4. 300 nm Features
Figure 5. 200 nm Features
Figure 6. 100 nm Features
Figure 7. Other Features
Figure 8. Global Europium Nanoparticle in Biological Sector Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Europium Nanoparticle in Biological Sector Market Share by Application: 2023 VS 2030
Figure 10. Tumor Marker Testing Case Studies
Figure 11. Thyroid Function Testing Case Studies
Figure 12. Sex Hormone Testing Case Studies
Figure 13. Infectious Disease Testing Case Studies
Figure 14. Cardiovascular and Cardiac Biomarkers Testing Case Studies
Figure 15. Other Case Studies
Figure 16. Europium Nanoparticle in Biological Sector Report Years Considered
Figure 17. Global Europium Nanoparticle in Biological Sector Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Europium Nanoparticle in Biological Sector Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Europium Nanoparticle in Biological Sector Market Share by Region: 2023 VS 2030
Figure 20. Global Europium Nanoparticle in Biological Sector Market Share by Players in 2023
Figure 21. Global Top Europium Nanoparticle in Biological Sector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Europium Nanoparticle in Biological Sector as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Europium Nanoparticle in Biological Sector Revenue in 2023
Figure 23. North America Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Europium Nanoparticle in Biological Sector Market Share by Country (2019-2030)
Figure 25. United States Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Europium Nanoparticle in Biological Sector Market Share by Country (2019-2030)
Figure 29. Germany Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Europium Nanoparticle in Biological Sector Market Share by Region (2019-2030)
Figure 37. China Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Europium Nanoparticle in Biological Sector Market Share by Country (2019-2030)
Figure 45. Mexico Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Europium Nanoparticle in Biological Sector Market Share by Country (2019-2030)
Figure 49. Turkey Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. UAE Europium Nanoparticle in Biological Sector Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 54. Bangs Laboratories, Inc. Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 55. Suzhou NanoMicro Technology Co Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 56. Polysciences Inc Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 57. CD Bioparticles Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 58. Hangzhou Bioeast Biotech Co Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 59. Nanjing Microoetection Revenue Growth Rate in Europium Nanoparticle in Biological Sector Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
